Royal Bank Of Canada Tekla Life Sciences Investors Transaction History
Royal Bank Of Canada
- $479 Billion
- Q4 2024
A detailed history of Royal Bank Of Canada transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, Royal Bank Of Canada holds 47,933 shares of HQL stock, worth $670,582. This represents 0.0% of its overall portfolio holdings.
Number of Shares
47,933
Previous 50,109
4.34%
Holding current value
$670,582
Previous $755,000
16.82%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding HQL
# of Institutions
76Shares Held
9.76MCall Options Held
0Put Options Held
0-
Saba Capital Management, L.P. New York, NY3.43MShares$48 Million1.11% of portfolio
-
Penserra Capital Management LLC Orinda, CA828KShares$11.6 Million0.2% of portfolio
-
Karpus Management, Inc. Pittsford, NY490KShares$6.85 Million0.23% of portfolio
-
Sit Investment Associates Inc Minneapolis, MN417KShares$5.83 Million0.12% of portfolio
-
Absolute Investment Advisers LLC400KShares$5.59 Million0.67% of portfolio
About TEKLA LIFE SCIENCES INVESTORS
- Ticker HQL
- Exchange NYSE
- Sector Financial Services
- Industry Asset Management
- Description
- Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...